Recipharm is a
leading contract
development and
manufacturing
organisation (CDMO)
headquartered in
Stockholm, Sweden.
We operate
development and
manufacturing
facilities in
France, Germany,
India, Israel,
Italy, Portugal,
Spain, Sweden, the
UK and the US and
are continuing to
grow and expand our
offering for our
customers. Employing
around 9,000 people,
we are focused on
supporting
pharmaceutical
companies with our
full service
offering, taking
products from early
development through
to commercial
production. For over
25 years we have
been there for our
clients throughout
the entire product
lifecycle, providing
pharmaceutical
expertise and
managing complexity,
time and time again.
Despite our growing
global footprint, we
conduct our business
as we always have
and continue to
deliver value for
money with each
customer’s
needs firmly at the
heart of all that we
do. That’s the
Recipharm way.
Secures supply of the API chloroquine phosphate for Klorokinfosf drug; ramps up production in the event that demand increases for potential COVID-19 therapy
A roundtable discussion about the serialization challenge and why some contract service providers and brand owners are skeptical of each other's readiness